Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
305
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Genetic Causes of Auditory Neuropathy: A Systematic Review.

Journal of clinical medicine·2026
Same author

Context-of-use-Guided Development and Validation of a Transthyretin Immunoassay: A Framework for Biomarker Assay Design.

The AAPS journal·2026
Same author

Real-World Outcomes of Chemiluminescence Immunoassay Implementation for <i>Mycobacterium tuberculosis</i> Infection Screening.

Open forum infectious diseases·2026
Same author

Mortality trends for diabetes mellitus, hypertension and cardiovascular disease among people living with and without HIV in Brazil during the COVID-19 pandemic, 2020-2022.

HIV medicine·2026
Same author

Evaluating the impact of electronic β-lactam allergy alert suppression on antibiotic prescribing practices.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Where Did this Come From: Lumbar Puncture for All Infants with Suspected Tuberculosis Disease?

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019.

Sarah Gorvetzian, Antonio G Pacheco, Erin Anderson

    Emerging Infectious Diseases
    |October 24, 2024
    PubMed
    Summary
    This summary is machine-generated.

    US-born individuals who completed tuberculosis (TB) treatment had higher mortality rates. Improving access to primary and HIV care for TB survivors is crucial for preventing deaths.

    Keywords:
    GeorgiaHIVHIV/AIDS and other retrovirusesUnited Statesbacteriamortalityrespiratory infectionstuberculosistuberculosis and other mycobacteria

    More Related Videos

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    1.8K
    A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
    10:41

    A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

    Published on: April 30, 2020

    13.9K

    Related Experiment Videos

    Last Updated: Jun 9, 2025

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    18.8K
    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    1.8K
    A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
    10:41

    A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

    Published on: April 30, 2020

    13.9K

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Diseases

    Background:

    • Limited data exist on post-treatment mortality for tuberculosis (TB) in the United States.
    • Understanding mortality risks for TB survivors is essential for improving long-term outcomes.

    Purpose of the Study:

    • To analyze mortality rates among adults in Georgia, USA, following completion of TB treatment.
    • To identify risk factors associated with death after TB treatment.

    Main Methods:

    • Retrospective cohort study analyzing data from January 1, 2008, to December 31, 2019.
    • Utilized the National Death Index for posttreatment mortality data.
    • Calculated standardized mortality ratios (SMRs) comparing TB survivors to the general population.

    Main Results:

    • Among 3,182 TB treatment survivors, 7.3% died by December 31, 2019.
    • The overall age- and sex-adjusted SMR for the TB cohort was 0.89.
    • US-born TB survivors had a significantly higher SMR of 1.56.
    • Factors associated with increased mortality included US-born status, HIV co-infection, alcohol use, diabetes, and end-stage renal disease.

    Conclusions:

    • TB treatment survivors, particularly US-born individuals, face elevated mortality risks.
    • Enhanced linkage to primary care and comprehensive HIV services may reduce posttreatment deaths.
    • Further research and targeted interventions are needed to improve long-term survival for TB patients.